(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -446.49%-854.33K | -98.22%-260.96K | -114.95%-1.07M | -105.57%-374.2K | -242.33%-811.01K | 849.86%246.57K | -185.50%-131.65K | -25.48%-497.93K | -68.78%-182.03K | -56.61%-236.91K |
Net income from continuing operations | 30.07%-904.7K | -55.71%-370.37K | -298.91%-3.94M | -1,318.73%-1.9M | -254.72%-513.76K | -124.69%-1.29M | -77.30%-237.86K | -34.55%-988.53K | 30.18%-133.78K | 28.68%-144.84K |
Operating gains losses | 2,060.31%3.8K | -88.14%506 | 236.34%631.23K | 184.23%666.02K | -337.71%-38.87K | 99.44%-194 | 227.56%4.27K | 1,255.84%187.68K | 4,712.53%234.32K | -1,343.90%-8.88K |
Depreciation and amortization | -82.05%317 | -81.32%316 | -37.79%4.55K | -93.01%123 | -45.51%965 | 4.81%1.77K | -19.12%1.69K | -15.45%7.31K | -19.42%1.76K | -18.42%1.77K |
Asset impairment expenditure | ---- | ---- | 662.60%1.74M | 465.71%879.52K | 157.33%6.47K | ---- | ---- | --228.12K | ---240.5K | ---11.28K |
Unrealized gains and losses of investment securities | --0 | --0 | 166.67%28K | 133.33%14K | ---4K | --0 | --18K | ---42K | ---42K | --0 |
Remuneration paid in stock | 34.52%34.98K | -44.78%23.7K | 447.28%128.85K | 4,506.14%42.75K | 262.50%17.19K | 334.76%26K | 260.83%42.91K | -82.36%23.54K | -94.74%928 | -82.35%4.74K |
Change In working capital | -119.40%-127.87K | 115.80%84.89K | 296.43%340.73K | -2,753.85%-78.6K | -255.74%-279K | 634.47%658.98K | -49.18%39.34K | -59.25%85.95K | -103.13%-2.75K | -435.24%-78.43K |
-Change in receivables | -459.60%-58.59K | 922.86%36.03K | 106.98%81 | 8,801.99%143.41K | -2,567.11%-136.38K | -45.68%-10.47K | 416.73%3.52K | -204.13%-1.16K | -64.97%1.61K | 554.98%5.53K |
-Change in prepaid assets | ---- | ---- | -1,638.13%-72K | ---- | ---- | ---- | ---- | -31.64%4.68K | ---- | ---- |
-Change in payables and accrued expense | -110.35%-69.28K | 36.44%48.87K | 400.61%412.65K | -1,558.26%-150.01K | -69.87%-142.61K | 550.99%669.45K | -50.66%35.82K | -59.39%82.43K | -111.36%-9.05K | -357.85%-83.95K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -446.49%-854.33K | -98.22%-260.96K | -114.95%-1.07M | -105.57%-374.2K | -242.33%-811.01K | 849.86%246.57K | -185.50%-131.65K | -25.48%-497.93K | -68.78%-182.03K | -56.61%-236.91K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 94.45%-18.81K | 94.05%-14.39K | 19.12%-284.9K | 3,858.22%179.72K | 142.66%116.21K | -346.26%-339.06K | -25,820.96%-241.78K | -24.33%-352.24K | 93.04%-4.78K | -245.12%-272.42K |
Net PPE purchase and sale | 89.09%-49.21K | 91.14%-14.39K | -52.48%-547.01K | 340.06%52.83K | 105.31%13.56K | -493.31%-450.99K | -2,934.38%-162.4K | 0.02%-358.74K | 68.04%-22.01K | -111.11%-255.37K |
Net business purchase and sale | ---- | ---- | --242.28K | --106.74K | ---- | ---- | ---- | --0 | --0 | ---- |
Net investment purchase and sale | ---- | ---- | --23.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net other investing changes | ---- | ---- | -156.56%-3.68K | -119.47%-3.35K | 44.97%-9.38K | 245,552.78%88.44K | -1,361.55%-79.38K | -84.58%6.5K | 11,945.45%17.23K | ---17.05K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 94.45%-18.81K | 94.05%-14.39K | 19.12%-284.9K | 3,858.22%179.72K | 142.66%116.21K | -346.26%-339.06K | -25,820.96%-241.78K | -24.33%-352.24K | 93.04%-4.78K | -245.12%-272.42K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 211.05%1.65M | 21,440.69%307.31K | -4.54%1.13M | 0 | 120,004.80%599.52K | -17.86%531.51K | -100.27%-1.44K | 94.40%1.18M | -450 | -500 |
Net common stock issuance | ---- | ---- | -4.54%1.13M | --0 | 226,019.20%1.13M | ---- | ---- | 94.40%1.18M | ---450 | ---500 |
Net other financing activities | -168.06%-361.74K | 21,440.69%307.31K | ---- | ---- | ---- | --531.51K | -92.00%-1.44K | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 211.05%1.65M | 21,440.69%307.31K | -4.54%1.13M | --0 | 120,004.80%599.52K | -17.86%531.51K | -100.27%-1.44K | 94.40%1.18M | ---450 | ---500 |
Net cash flow | ||||||||||
Beginning cash position | 124.76%329.92K | -43.01%298.59K | 269.45%523.95K | -30.41%487.81K | -51.05%587.8K | -76.87%146.79K | 269.45%523.95K | -33.69%141.82K | 118.42%700.97K | 118.35%1.2M |
Current changes in cash | 77.70%780.13K | 108.53%31.96K | -167.72%-225.6K | -3.86%-194.48K | 81.31%-95.27K | -18.43%439.02K | -176.19%-374.87K | 566.34%333.12K | -6.06%-187.26K | -121.46%-509.83K |
Effect of exchange rate changes | -118.85%-376 | 72.26%-637 | -99.51%242 | -48.50%5.27K | -147.66%-4.73K | -92.92%2K | -437.15%-2.3K | 8,029.77%49.01K | 501.45%10.23K | 751.42%9.92K |
End cash Position | 88.78%1.11M | 124.76%329.92K | -43.01%298.59K | -43.01%298.59K | -30.41%487.81K | -51.05%587.8K | -76.87%146.79K | 269.45%523.95K | 269.45%523.95K | 118.42%700.97K |
Free cash from | -341.99%-903.54K | 6.36%-275.35K | -83.15%-1.62M | -29.28%-297.87K | -66.77%-820.95K | -87.73%-204.43K | -471.37%-294.05K | -16.64%-883.04K | -30.41%-230.4K | -80.83%-492.28K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data